Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bonavida

Showing results (181-190 of 276) with videos related to

Pageof 28
Sort By:
International Journal of Oncology|May 3, 2011
Normal human oral keratinocytes are more sensitive to N-methyl-N'-nitro-N-nitrosoguanidine-induced cytotoxicity and apoptosis than HPV-immortalized oral keratinocytesJ Baek, C Bertolami, B Bonavida, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1995
Enhanced susceptibility of c-myc antisense oligonucleotide-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytesY Mizutani, B Bonavida, M Fukumoto, et al.
Gynecologic Oncology|February 1, 1993
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotypeJ T Safrit, J S Berek, B Bonavida
Oncogene|November 30, 2005
Transcription factor YY1: structure, function, and therapeutic implications in cancer biologyS Gordon, G Akopyan, H Garban, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancyJ D Katz, L T Lebow, B Bonavida
Natural Immunity and Cell Growth Regulation|January 1, 1990
Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiersY Nio, J Zighelboim, J S Berek, et al.
Journal of Lipid Mediators and Cell Signalling|February 1, 1994
Qualitative and quantitative analysis of subpopulations of cytotoxic effector cells by flow cytometryB Bonavida, M Braquet, L T Lebow, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432Y Nio, J Zighelboim, J S Berek, et al.
Journal of Clinical Immunology|November 1, 1988
Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cellsJ D Katz, P Nishanian, R Mitsuyasu, et al.
Anticancer Research|March 1, 1990
Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiersY Nio, J Zighelboim, J S Berek, et al.
Pageof 28

Showing results (181-190 of 276) with videos related to

Sort By:
Pageof 28
International Journal of Oncology|May 3, 2011
Normal human oral keratinocytes are more sensitive to N-methyl-N'-nitro-N-nitrosoguanidine-induced cytotoxicity and apoptosis than HPV-immortalized oral keratinocytesJ Baek, C Bertolami, B Bonavida, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1995
Enhanced susceptibility of c-myc antisense oligonucleotide-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytesY Mizutani, B Bonavida, M Fukumoto, et al.
Gynecologic Oncology|February 1, 1993
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotypeJ T Safrit, J S Berek, B Bonavida
Oncogene|November 30, 2005
Transcription factor YY1: structure, function, and therapeutic implications in cancer biologyS Gordon, G Akopyan, H Garban, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancyJ D Katz, L T Lebow, B Bonavida
Natural Immunity and Cell Growth Regulation|January 1, 1990
Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiersY Nio, J Zighelboim, J S Berek, et al.
Journal of Lipid Mediators and Cell Signalling|February 1, 1994
Qualitative and quantitative analysis of subpopulations of cytotoxic effector cells by flow cytometryB Bonavida, M Braquet, L T Lebow, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432Y Nio, J Zighelboim, J S Berek, et al.
Journal of Clinical Immunology|November 1, 1988
Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cellsJ D Katz, P Nishanian, R Mitsuyasu, et al.
Anticancer Research|March 1, 1990
Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiersY Nio, J Zighelboim, J S Berek, et al.
Pageof 28